These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34155901)

  • 1. The Cell Surface Receptors Ror1/2 Control Cardiac Myofibroblast Differentiation.
    Chavkin NW; Sano S; Wang Y; Oshima K; Ogawa H; Horitani K; Sano M; MacLauchlan S; Nelson A; Setia K; Vippa T; Watanabe Y; Saucerman JJ; Hirschi KK; Gokce N; Walsh K
    J Am Heart Assoc; 2021 Jul; 10(13):e019904. PubMed ID: 34155901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast Smad7 Induction Protects the Remodeling Pressure-Overloaded Heart.
    Humeres C; Shinde AV; Tuleta I; Hernandez SC; Hanna A; Huang S; Venugopal H; Aguilan JT; Conway SJ; Sidoli S; Frangogiannis NG
    Circ Res; 2024 Jul; 135(3):453-469. PubMed ID: 38899461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism.
    Xia Y; Dobaczewski M; Gonzalez-Quesada C; Chen W; Biernacka A; Li N; Lee DW; Frangogiannis NG
    Hypertension; 2011 Nov; 58(5):902-11. PubMed ID: 21947471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of delta-like 1 homologue accelerates fibroblast-myofibroblast differentiation and induces myocardial fibrosis.
    Rodriguez P; Sassi Y; Troncone L; Benard L; Ishikawa K; Gordon RE; Lamas S; Laborda J; Hajjar RJ; Lebeche D
    Eur Heart J; 2019 Mar; 40(12):967-978. PubMed ID: 29668883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
    Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC
    J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure.
    Bradley JM; Spaletra P; Li Z; Sharp TE; Goodchild TT; Corral LG; Fung L; Chan KWH; Sullivan RW; Swindlehurst CA; Lefer DJ
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H563-H570. PubMed ID: 29949382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of Thy1 defines a pathogenic fraction of cardiac fibroblasts in heart failure.
    Li Y; Song D; Mao L; Abraham DM; Bursac N
    Biomaterials; 2020 Apr; 236():119824. PubMed ID: 32028169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.
    Higashikuni Y; Tanaka K; Kato M; Nureki O; Hirata Y; Nagai R; Komuro I; Sata M
    J Am Heart Assoc; 2013 Nov; 2(6):e000267. PubMed ID: 24249711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-21-Dependent Macrophage-to-Fibroblast Signaling Determines the Cardiac Response to Pressure Overload.
    Ramanujam D; Schön AP; Beck C; Vaccarello P; Felician G; Dueck A; Esfandyari D; Meister G; Meitinger T; Schulz C; Engelhardt S
    Circulation; 2021 Apr; 143(15):1513-1525. PubMed ID: 33550817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program.
    Russo I; Cavalera M; Huang S; Su Y; Hanna A; Chen B; Shinde AV; Conway SJ; Graff J; Frangogiannis NG
    Circ Res; 2019 Apr; 124(8):1214-1227. PubMed ID: 30686120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scleraxis and fibrosis in the pressure-overloaded heart.
    Nagalingam RS; Chattopadhyaya S; Al-Hattab DS; Cheung DYC; Schwartz LY; Jana S; Aroutiounova N; Ledingham DA; Moffatt TL; Landry NM; Bagchi RA; Dixon IMC; Wigle JT; Oudit GY; Kassiri Z; Jassal DS; Czubryt MP
    Eur Heart J; 2022 Dec; 43(45):4739-4750. PubMed ID: 36200607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis.
    Molkentin JD; Bugg D; Ghearing N; Dorn LE; Kim P; Sargent MA; Gunaje J; Otsu K; Davis J
    Circulation; 2017 Aug; 136(6):549-561. PubMed ID: 28356446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model.
    Yang R; Song Z; Wu S; Wei Z; Xu Y; Shen X
    Atherosclerosis; 2018 Dec; 279():23-31. PubMed ID: 30399463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription factor scleraxis is a critical regulator of cardiac fibroblast phenotype.
    Bagchi RA; Roche P; Aroutiounova N; Espira L; Abrenica B; Schweitzer R; Czubryt MP
    BMC Biol; 2016 Mar; 14():21. PubMed ID: 26988708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol.
    Nishiga M; Horie T; Kuwabara Y; Nagao K; Baba O; Nakao T; Nishino T; Hakuno D; Nakashima Y; Nishi H; Nakazeki F; Ide Y; Koyama S; Kimura M; Hanada R; Nakamura T; Inada T; Hasegawa K; Conway SJ; Kita T; Kimura T; Ono K
    Circ Res; 2017 Mar; 120(5):835-847. PubMed ID: 27920122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.
    Salvador AM; Nevers T; Velázquez F; Aronovitz M; Wang B; Abadía Molina A; Jaffe IZ; Karas RH; Blanton RM; Alcaide P
    J Am Heart Assoc; 2016 Mar; 5(3):e003126. PubMed ID: 27068635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling.
    Svystonyuk DA; Ngu JM; Mewhort HE; Lipon BD; Teng G; Guzzardi DG; Malik G; Belke DD; Fedak PW
    J Transl Med; 2015 May; 13():147. PubMed ID: 25948488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload.
    Mohammadzadeh N; Melleby AO; Palmero S; Sjaastad I; Chakravarti S; Engebretsen KVT; Christensen G; Lunde IG; Tønnessen T
    Cardiology; 2020; 145(3):187-198. PubMed ID: 31968347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the Mesenchymal Stromal/Stem Cell Marker Meflin in Cardiac Tissue Repair and the Development of Diastolic Dysfunction.
    Hara A; Kobayashi H; Asai N; Saito S; Higuchi T; Kato K; Okumura T; Bando YK; Takefuji M; Mizutani Y; Miyai Y; Saito S; Maruyama S; Maeda K; Ouchi N; Nagasaka A; Miyata T; Mii S; Kioka N; Worthley DL; Murohara T; Takahashi M; Enomoto A
    Circ Res; 2019 Aug; 125(4):414-430. PubMed ID: 31221024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.